术前T2加权MRI上的局灶性乳腺水肿作为临床淋巴结阴性T1-2期乳腺癌前哨淋巴结转移的预测因子:一项回顾性双中心研究
这项回顾性双中心研究纳入381例临床淋巴结阴性(cN0)T1-2期浸润性乳腺癌患者,评估术前T2加权MRI上的乳腺水肿对前哨淋巴结(SLN)转移的预测价值。乳腺水肿在两个队列中均与前哨淋巴结转移独立相关,仅基于乳腺水肿的模型在主队列中AUC为0.738(95%CI:0.667-0.809)、阴性预测值(NPV)为89%,验证队列表现一致。乳腺水肿联合临床病理特征(年龄和分子亚型)的联合模型较单用临床病理特征模型显著提高预测效能(主队列AUC:0.822 vs. 0.654,p<0.001;NPV:92% vs. 83%;验证队列AUC:0.793 vs. 0.616,p=0.021;NPV:92% vs. 88%)。
要点
- 术前T2加权MRI上的乳腺水肿在两个队列中均与前哨淋巴结转移独立相关。
- 仅基于乳腺水肿的模型主队列AUC为0.738(95%CI:0.667-0.809)、NPV为89%。
- 乳腺水肿联合年龄和分子亚型的联合模型主队列AUC为0.822、NPV为92%。
核心结论
- 乳腺水肿与前哨淋巴结转移独立相关,乳腺水肿联合临床病理特征可能有助于识别前哨淋巴结转移风险较低的患者,可能辅助前哨淋巴结活检省略决策。
研究设计与样本
- 回顾性双中心研究,纳入2016年1月至2019年12月两家独立机构中经临床检查、超声和MRI确认为cN0的浸润性乳腺癌女性患者,主队列267例,验证队列114例。
关键影像表现/征象
- 评估术前T2加权图像上的乳腺水肿。
- 主队列267例中67例(25.1%)观察到前哨淋巴结转移。
- 验证队列114例中24例(21.1%)观察到前哨淋巴结转移。
诊断标准与关键数值
- 仅基于乳腺水肿的模型主队列AUC为0.738(95%CI:0.667-0.809),NPV为89%。
- 仅基于乳腺水肿的模型验证队列表现与主队列一致。
- 联合模型(乳腺水肿联合年龄和分子亚型)主队列AUC为0.822,NPV为92%。
- 仅用临床病理特征(年龄和分子亚型)的模型主队列AUC为0.654,NPV为83%;联合模型较其AUC提高,p<0.001。
- 联合模型验证队列AUC为0.793,NPV为92%;仅用临床病理特征模型验证队列AUC为0.616,NPV为88%;联合模型较其AUC提高,p=0.021。
临床应用与阅片要点
- 术前T2加权MRI上评估乳腺水肿可能有助于识别前哨淋巴结转移风险较低的患者。
- 乳腺水肿联合临床病理特征(年龄和分子亚型)可能辅助前哨淋巴结活检省略决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the predictive value of breast edema identified on preoperative T2-weighted MRI for sentinel lymph node (SLN) metastasis in patients with clinically node-negative (cN0) T1 and T2 stage invasive breast cancer.
METHODS: In this retrospective bicentric study, women with cN0 invasive breast cancer- confirmed by clinical examination, ultrasound, and MRI- who underwent preoperative breast MRI between January 2016 and December 2019 at two independent institutions were included. Breast edema on T2-weighted images was assessed. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of SLN metastasis. The area under the receiver operating characteristic curve (AUC) and negative predictive value (NPV) were calculated.
RESULTS: Of the 381 patients, SLN metastasis was observed in 67 of 267 patients (25.1 %) in the primary cohort and in 24 of 114 patients (21.1 %) in the validation cohort. Breast edema was independently associated with SLN metastasis in both cohorts. A model based solely on breast edema achieved an AUC of 0.738 (95 % CI: 0.667-0.809) and an NPV of 89 % in the primary cohort, with consistent performance in the validation cohort. Compared with a model using only clinicopathological features (age and molecular subtype), the combined model incorporating breast edema significantly improved predictive performance (AUC: 0.822 vs. 0.654, p < 0.001; NPV: 92 % vs. 83 %), which was confirmed in the validation cohort (AUC: 0.793 vs. 0.616, p = 0.021; NPV: 92 % vs. 88 %).
CONCLUSION: Breast edema is independently associated with SLN metastasis. Breast edema combing with clinical-pathological features may help identify patients at lower risk of SLN metastasis, potentially aiding in SLNB omission decisions.
引用
- Xie T, Huang Y, Xiao Q, et al. Preoperative focal breast edema on T2-weighted MRI as a predictor of sentinel lymph node metastasis in clinically node-negative T1-2 breast cancer: A retrospective bicentric study. Eur J Radiol. 2025. PMID: 40729989. doi:10.1016/j.ejrad.2025.112328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。